These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1859505)
21. Stroke prevention in the elderly. Besdine RW Conn Med; 1993 May; 57(5):287-92. PubMed ID: 8319444 [TBL] [Abstract][Full Text] [Related]
22. Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials. Albers GW; Am J Manag Care; 2004 Dec; 10(14 Suppl):S462-9; discussion S469-73. PubMed ID: 15696910 [TBL] [Abstract][Full Text] [Related]
23. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153 [TBL] [Abstract][Full Text] [Related]
24. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med; 1978 Oct; 299(17):953-5. PubMed ID: 357975 [No Abstract] [Full Text] [Related]
25. [Role of endarterectomy in the secondary prevention of cerebrovascular accidents: results of the European Carotid Surgery Trial (ECST)]. Ferro JM; Oliveira V; Melo TP; Crespo M; Lopes J; Fernandes e Fernandes J; DamiĆ£o A; Campos JG Acta Med Port; 1991; 4(4):227-8. PubMed ID: 1767717 [No Abstract] [Full Text] [Related]
28. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Gent M; Blakely JA; Hachinski V; Roberts RS; Barnett HJ; Bayer NH; Carruthers SG; Collins SM; Gawel MG; Giroux-Klimek M Stroke; 1985; 16(3):416-24. PubMed ID: 2988158 [TBL] [Abstract][Full Text] [Related]
31. Interactions between stroke data banks and clinical trials. Sacco RL Neuroepidemiology; 1994; 13(6):275-82. PubMed ID: 7800105 [TBL] [Abstract][Full Text] [Related]
32. Problems in design of stroke treatment trials. Spence JD; Donner A Stroke; 1982; 13(1):94-9. PubMed ID: 7064185 [TBL] [Abstract][Full Text] [Related]
33. Stroke prevention trials: how many enrollees can be expected by site? Lukovits TG; Thomas K; Gorelick PB Neurology; 1999 Mar; 52(5):1101-2. PubMed ID: 10102444 [No Abstract] [Full Text] [Related]
34. American Heart Association Prevention Conference. IV: Prevention and Rehabilitation of Stroke. Keynote Address: properly designed trials and identification of risk factors. Dyken ML Stroke; 1997 Jul; 28(7):1498-500. PubMed ID: 9227706 [No Abstract] [Full Text] [Related]
35. The Fragrant Hill Declaration on Cerebral Vascular Disease. Wang YJ; ; CNS Neurosci Ther; 2015 Dec; 21(12):919-20. PubMed ID: 26768525 [No Abstract] [Full Text] [Related]
36. Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial. Strandberg TE; Tilvis RS Lancet; 1997 Aug; 350(9075):442. PubMed ID: 9259675 [No Abstract] [Full Text] [Related]
37. Stroke research--challenge for 1990s. Gunatilake S Ceylon Med J; 1992 Mar; 37(1):1-4. PubMed ID: 1581988 [No Abstract] [Full Text] [Related]